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Table 1
Frequency Distribution of Size Differences between
Microsatellite Alleles
No. of Repeats Ge´ne´thon SSMM MSMM
1 .812 .936 .810
2 .111 .047 .126
3 .036 .011 .037
4 .016 .004 .014
5 .011 .001 .007
6 .005 .001 .003
7 .003 .000 .002
8 .002 .000 .001
9 .001 .000 .001
10 .001 .000 .000
NOTE.—“No. of Repeats” indicates the difference in the number of
dinucleotide repeats between adjacent alleles that have been ranked
by their absolute size. SSMM  single-step mutation model. MSMM
 multiple-step mutation model (m  2), no mutational bias.
We have found that microsatellite allele frequency dis-
tributions tend to be positively skewed in favor of longer
alleles, which is in agreement with an analysis of CAG
repeats in the Huntington disease gene (Rubinsztein et
al. 1994) and the unpublished results of W. Amos and
D. Rubinsztein (cited in Rubinsztein et al. 1995). Our
computer simulation results suggest that the underlying
mutational model for generating new microsatellite al-
leles is likely to be asymmetrical and multistep. MSMM
models with an absorbing boundary or with a muta-
tional bias in favor of larger alleles can generate allele
distributions that closely resemble those observed in the
Ge´ne´thon data. Models of directional evolution that re-
sult from mutational bias have been recently discussed
(Rubinsztein et al. 1995; Primmer et al. 1996). Finally,
the empirical mean frequencies of the ranked alleles de-
rived from the Ge´ne´thon analysis provide useful prior
distributions to those applying Bayesian smoothing tech-
niques (Lange 1997) to (AC)n microsatellite allele fre-
quency estimates.
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Some Underlooked Properties of the Multifactorial/
Threshold Model
To the Editor:
Some years ago, when the multifactorial/threshold
(MFT) model was beginning to be recognized (by some)
as a useful way of thinking about the causes of common
congenital malformations, I noted one of its implica-
tions. “It follows from theMFTmodel that in conditions
appearing more often in one sex than the other, the sex
ratio should change as the frequency changes” (Fraser
1971, p. 90). I suggested that such changes in the sex
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Figure 1 Multifactorial thresholdmodel for a condition inwhich
males and females have different frequencies. For details, see text .
ratio of a condition might be a more sensitive indicator
of changes in its frequency than direct counts would be.
Since then, there have been several relevant examples of
changes in sex ratio with differences in frequency of a
trait. These have evoked a number of explanations that,
though ingenious, may be unnecessary; the answer may
lie in the above-mentioned property of the MFT model.
The MFT model postulates a continuous distribution
of “liability” to a particular defect and a threshold sep-
arating the continuous distribution into discontinuous
parts, with only those individuals falling beyond the
threshold having the defect. Cleft palate in the mouse is
a classic example, with substantial experimental support
(Fraser 1976). In this case, liability is a reflection of the
developmental stage at which the palate shelves move
toward closure. The threshold is the latest stage at which
closure is still possible. Embryos in which shelf move-
ment occurs later than this have cleft palate. Thus, the
embryos with later closure are more susceptible, or liable
(Fraser 1980a).
A number of predictions can be made from the MFT
model, relating recurrence risk to sex of proband, se-
verity of defect, number of affected relatives, degree of
relationship to proband, and population frequency of
the trait. These have been discussed extensively else-
where (Fraser 1976, 1980b). Note that all these prop-
erties relate to how the frequency of a trait changes as
the position of the liability distribution changes relative
to the threshold and not to whether the distribution is
normal (polygenic) or multimodal (several genes with
low penetrance).
Two other predictions of the MFT model, to be dis-
cussed in this article, have been largely overlooked. The
first of these addresses how changes in the sex ratio of
a MFT trait can reveal changes in liability. For instance,
the American Society for Human Genetics Statement on
Behavioral Genetics (Sherman et al. 1997) uses emo-
tional stability as an example of how sex-ratio differ-
ences are exaggerated at the tails of the frequency dis-
tribution in conditions where the distribution differs in
the two sexes. For this multifactorial trait, males have
a somewhat higher mean emotional stability score than
females, but at the upper 1% of the distribution there
is a striking excess of males. Figure 1 illustrates why.
The dashed curve represents the distribution of “liability
to stability” scores for males, and the solid curve that
for females. The (arbitrary) threshold, T2, demarcates
the upper 1% of the population, who could be consid-
ered those with the “ultrastability” trait. Note that in
this group there is an obvious excess of males; that is,
there are many more males than females in the area
under the curve beyond T2. If the threshold is set at
(say) the 5% level (T1), there will be an increase in
frequency of the trait, but the excess of males beyond
the T1 level is not as great as it was beyond the T2
threshold (i.e., the proportion of “ultrastable” males is
smaller). Thus, the sex ratio of “ultrastable” individuals
shifts toward equality as the frequency of the trait (num-
ber of individuals beyond the threshold) increases.
For congenital malformations, one cannot see the dis-
tribution of liability for the trait but only the proportion
of individuals who fall beyond the threshold (the fre-
quency of the trait). In cleft lip, with or without cleft
palate (CLP), for example, more males than females are
affected, so we infer that the liability distribution for
males is farther to the right than for females. Figure 1
now represents the distributions of liability to CLP for
males (dashed line) and females (solid line); the threshold
separates those with the trait (in the tail of the distri-
bution) from those without it. Again, if the distribution
of liability shifts to the right, so that the frequency in-
creases, the sex ratio shifts toward equality. (For sim-
plicity’s sake, fig. 1 illustrates this by shifting the thresh-
olds to the left, rather than the distributions to the right).
CLP provides several examples of this effect. For ex-
ample, one would expect liability to be lower in families
with one affected individual (simplex) than in those with
more than one (multiplex), so the sex ratio should be
closer to 1 in the multiplex families—and it is. The sex
ratio in simplex versus multiplex families is reported as
2.0 versus 1.5 by Fraser (1980b) and as 3.2 versus 1.4
by Ray et al. (1993). An explanation is suggested by Ray
et al. Perhaps “the loading of environmental factors pre-
disposing to CLP is higher in multiplex families and
results in a higher frequency of the less susceptible sex
(females) becoming affected” (Ray et al. 1993, p. 1010).
Possibly, but the simplest explanation is that the sex ratio
shift is just what is expected for an MFT trait, with
different liability distributions for the two sexes.
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Figure 2 Month of birth for children with CLP, by sex, for
Montreal and Denmark. For details, see text. The top two graphs
represent males.
One might also expect that the liability distribution
of CLP would be farther to the right in cases with as-
sociated malformations than in “isolated” cases, since,
for one thing, this group would include some cases with
syndromes in which CLP is a recognized component.
For nonsyndromic, or “isolated,” cases of cleft lip, the
liability distribution would cross the threshold at a point
where ∼1 case in 1,000 would fall beyond the threshold,
this being the frequency of CLP. For “syndromic” CLP
(with reduced penetrance for CLP, of course) the pro-
portion of patients with the syndrome who have CLP
would be much higher than this, or else CLP would not
be recognized as part of the syndrome. For cases inwhich
the associated malformations were both caused by a te-
ratogen, the liability to CLP in exposed embryos would
also presumably be higher than in the general popula-
tion. Thus, cases with associated malformations should
have a liability distribution farther to right, and therefore
a lower sex ratio, than those without them. This has
been reported by Ka¨llen and Harris (1996), who found
a sex ratio of 1.3 for those with versus 1.9 for those
without associated malformations. The authors suggest
that mutants with associated malformations consist of
two subgroups: one equivalent to the children with iso-
lated facial clefts and another with a normal sex ratio.
This is a possibility, but one does not need another ex-
planation; the MFT model predicts it.
This phenomenon is not limited to CLP. Lubinsky
(1997), in an interesting article on sex-biased anomalies,
points out that the sex ratio shifts toward equality in
patients with versus those without additional malfor-
mations in the case of anencephaly, spina bifida, ence-
phalocele, single umbilical artery, and diaphragmatic
hernia. He postulates that these malformationsmay have
complex and heterogeneous origins and that “with dual
origins ‘strong’ events could increase the involvement of
otherwise minor second processes with opposite bias
from the primary disturbance” (p. 227). This is ingen-
ious, but would it escape Occam’s razor? The MFT
model provides a simpler explanation.
A final example comes from my own experience. The
gene for the autosomal dominant Van der Woude, or
lip-pit syndrome, produces CLP in some carriers and
isolated cleft palate (CP) in others. I thought it would
be interesting to see if the cases of CLP and CP in families
with this syndrome showed the same excess of males in
CLP and females in CP patients that they do in non-
syndromic patients. To my surprise, they did not; both
sex ratios shifted toward equality. “But of course, stu-
pid,” I said to myself. Both malformations have a higher
penetrance in the syndrome than they do in isolated
cases, so the shift in sex ratio toward equality is just
what one would expect.
Another overlooked prediction from the MFT model,
for traits with sex ratios deviating from 1, is that epi-
demiological variations are moremanifest in the sexwith
the higher frequency. Observe in figure 1 that as the
distribution is moved to the right (or the threshold to
the left) and the frequency increases, the slope of the
curve at the threshold increases. It is much steeper at T1
than at T2, but more so for males (dotted curve) than
for females. This means that a change in liability for a
rare trait, where the threshold is near the tail of the
distribution, should result in a smaller change in fre-
quency than it would for a more frequent trait, where
the threshold is farther to the left relative to the distri-
bution. Thus, anything altering liability would lead to
a greater change in frequency in the sex with the higher
frequency. So, in a search for factors that alter liability,
and thus change the frequency, any change would be
more discernible in the sex with the greatest frequency.
Thus, one would expect the variation in frequency with
various epidemiological factors to be more apparent in
females in the case of anencephaly (which is more fre-
quent in females), and more apparent in males in the
case of CLP.
Since neural-tube defects show variations with season
of birth, which could be in part a result of seasonal
variations in maternal vitamin intake, I wondered
whether CLP would also show an association with sea-
son of birth, since there is growing evidence that liability
to CLP varies with maternal vitamin intake (Tolarova
and Harris 1995; Czeizel et al. 1996; Shaw et al. 1997).
For the above reasons, such an effect should be more
evident in males. Previous studies of variation in season
of birth for CLP, with sexes combined, have been in-
consistent. A review of cases of CLP seen at theMontreal
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Children’s Hospital from 1950 to 1996 does indeed
show a significant variation in males (fig. 2), with a peak
around July–August, which is not present in the females
(Fraser and Gwynn 1998). Figure 2 also shows data on
season of birth from Fogh-Andersen’s classicmonograph
on CLP (1942), which we have analyzed by sex. There
is a significant variation in males, with a peak in
April–May but not in females (F. C. Fraser and X. N.
Rahnema, unpublished data). A similar peak for CLP
(sexes combined) is reported from Finland (Rintala
1983), and it would be interesting to see whether this
variation was more evident in males in this and other
populations. The reasons for these variations remain to
be clarified. There is some preliminary evidence that the
effect may have diminished or disappeared in recent
years. But, whatever the explanation, the point here is
that for threshold traits that are more frequent in one
sex than the other, epidemiological variations may be
revealed more effectively by examining the sexes
separately.
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